Emanuele Ammatuna: Time to reconsider 3+7 for older patients fit for allogenic stem cell transplantation

Emanuele Ammatuna, Hematologist at University Medical Center Groningen, shared on LinkedIn:

“Time to reconsider 3+7 for older patients fit for allogenic stem cell transplantation. The addition of a bcl-2 inhibitor to HMA should be the next investigation in this category of patients.”